Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 180.00
-2.10 (-1.15%)
Mar 9, 2026, 5:29 PM CET
Xvivo Perfusion AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 292.09 | 415.52 | 546.09 | 246.55 | 398.7 | Upgrade
|
| Cash & Short-Term Investments | 292.09 | 415.52 | 546.09 | 246.55 | 398.7 | Upgrade
|
| Cash Growth | -29.70% | -23.91% | 121.50% | -38.16% | 12.55% | Upgrade
|
| Accounts Receivable | 147.66 | 117.29 | 98.13 | 94.5 | 52.04 | Upgrade
|
| Other Receivables | - | 23.74 | 20.25 | 9.76 | 11.88 | Upgrade
|
| Receivables | 147.66 | 141.04 | 118.37 | 104.26 | 63.91 | Upgrade
|
| Inventory | 248.46 | 227.41 | 141.6 | 106.57 | 77.59 | Upgrade
|
| Prepaid Expenses | - | 29.11 | 20.34 | 10.14 | 7.34 | Upgrade
|
| Total Current Assets | 688.21 | 813.08 | 826.41 | 467.51 | 547.53 | Upgrade
|
| Property, Plant & Equipment | 213.88 | 149.04 | 97.55 | 47.58 | 26.3 | Upgrade
|
| Long-Term Investments | - | 0.9 | 0.58 | 0.41 | 1.16 | Upgrade
|
| Goodwill | 610.06 | 682.48 | 591.39 | 625.32 | 460.23 | Upgrade
|
| Other Intangible Assets | 39.61 | 48.7 | 30.46 | 8.49 | 8.66 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 32.45 | 50.71 | 39.27 | 42.17 | Upgrade
|
| Long-Term Deferred Charges | 800.68 | 676.09 | 598.51 | 544.51 | 456.55 | Upgrade
|
| Other Long-Term Assets | 21.67 | - | - | - | - | Upgrade
|
| Total Assets | 2,374 | 2,403 | 2,196 | 1,733 | 1,543 | Upgrade
|
| Accounts Payable | - | 39.45 | 36.05 | 38.47 | 21.45 | Upgrade
|
| Accrued Expenses | - | 85.08 | 68.94 | 52.65 | 46.96 | Upgrade
|
| Short-Term Debt | 11.56 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | 10.92 | 10.27 | 5.55 | 4.2 | Upgrade
|
| Current Income Taxes Payable | - | 11.93 | 11.87 | 1.28 | 0.3 | Upgrade
|
| Current Unearned Revenue | - | 13.47 | 3.69 | 3.17 | 3.01 | Upgrade
|
| Other Current Liabilities | 107.82 | 16.67 | 3.66 | 33.77 | 28.6 | Upgrade
|
| Total Current Liabilities | 119.38 | 177.51 | 134.49 | 134.9 | 104.52 | Upgrade
|
| Long-Term Leases | 113.17 | 23.13 | 21.17 | 4.46 | 1.52 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 27.85 | 29.29 | 25.77 | 25.08 | Upgrade
|
| Other Long-Term Liabilities | 28.11 | 17.48 | 65.62 | 137.83 | 126.02 | Upgrade
|
| Total Liabilities | 260.65 | 245.97 | 250.57 | 302.95 | 257.15 | Upgrade
|
| Common Stock | 0.82 | 0.81 | 0.81 | 0.76 | 0.75 | Upgrade
|
| Additional Paid-In Capital | 1,785 | 1,772 | 1,764 | 1,314 | 1,253 | Upgrade
|
| Retained Earnings | 316.91 | 291.76 | 119.57 | 27.75 | 9.28 | Upgrade
|
| Comprehensive Income & Other | 10.65 | 92.19 | 60.89 | 87.78 | 22.09 | Upgrade
|
| Shareholders' Equity | 2,113 | 2,157 | 1,945 | 1,430 | 1,285 | Upgrade
|
| Total Liabilities & Equity | 2,374 | 2,403 | 2,196 | 1,733 | 1,543 | Upgrade
|
| Total Debt | 124.72 | 34.04 | 31.44 | 10.01 | 5.72 | Upgrade
|
| Net Cash (Debt) | 167.37 | 381.48 | 514.65 | 236.54 | 392.98 | Upgrade
|
| Net Cash Growth | -56.13% | -25.88% | 117.58% | -39.81% | 13.24% | Upgrade
|
| Net Cash Per Share | 5.30 | 12.05 | 17.19 | 8.01 | 13.58 | Upgrade
|
| Filing Date Shares Outstanding | 31.5 | 31.5 | 31.5 | 29.83 | 29.5 | Upgrade
|
| Total Common Shares Outstanding | 31.5 | 31.5 | 31.5 | 29.83 | 29.5 | Upgrade
|
| Working Capital | 568.83 | 635.57 | 691.92 | 332.61 | 443.01 | Upgrade
|
| Book Value Per Share | 67.10 | 68.47 | 61.75 | 47.94 | 43.58 | Upgrade
|
| Tangible Book Value | 1,464 | 1,426 | 1,323 | 796.33 | 816.56 | Upgrade
|
| Tangible Book Value Per Share | 46.47 | 45.26 | 42.01 | 26.69 | 27.68 | Upgrade
|
| Machinery | - | 217.57 | 153.61 | 98.52 | 68.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.